沪深市场个股详情
002107 沃华医药
- 5.30
- +0.10+1.92%
休市中 12/20 15:00 (北京)
30.59亿总市值126.19市盈率TTM
5.34最高价5.22最低价5.42万手成交量5.22今开5.20昨收2872.12万成交额0.95%换手率51.96市盈率(静)5.77亿总股本6.1452周最高4.47市净率30.19亿流通值2.9552周最低5.72涨停价5.70亿流通股31.19历史最高4.68跌停价2.31%振幅1.09历史最低0.25股息TTM5.30平均价2.53万手内盘4.72%股息率TTM100股每手2.88万手外盘
沃华医药关键统计数据
全部
显示同比
| (Q9)2024/09/30 | (Q6)2024/06/30 | (Q3)2024/03/31 | (FY)2023/12/31 | (Q9)2023/09/30 | (Q6)2023/06/30 | (Q3)2023/03/31 | (FY)2022/12/31 | (Q9)2022/09/30 | (Q6)2022/06/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | -19.50%5.77亿 | -19.73%3.95亿 | -8.49%2.15亿 | -10.38%9.1亿 | -4.84%7.16亿 | -2.24%4.92亿 | -9.29%2.35亿 | 7.65%10.15亿 | 5.88%7.53亿 | -2.25%5.04亿 |
| 营业收入 | -19.50%5.77亿 | -19.73%3.95亿 | -8.49%2.15亿 | -10.38%9.1亿 | -4.84%7.16亿 | -2.24%4.92亿 | -9.29%2.35亿 | 7.65%10.15亿 | 5.88%7.53亿 | -2.25%5.04亿 |
| 其他业务收入 | ---- | -27.52%160.76万 | ---- | 133.44%440.34万 | ---- | 1,147.70%221.79万 | ---- | 114.74%188.63万 | ---- | -32.23%17.78万 |
| 营业总成本 | -17.42%5.54亿 | -17.21%3.83亿 | -2.39%2.07亿 | -5.03%8.57亿 | -0.83%6.71亿 | 4.48%4.63亿 | -8.16%2.12亿 | 20.60%9.02亿 | 19.75%6.77亿 | 11.83%4.43亿 |
| 营业成本 | -8.76%1.6亿 | -8.50%1.1亿 | 0.91%5,831.33万 | -7.35%2.32亿 | -6.62%1.75亿 | -4.39%1.2亿 | -12.37%5,778.86万 | 18.13%2.51亿 | 22.49%1.88亿 | 18.90%1.25亿 |
| 营业税金及附加 | -19.16%955.3万 | -24.06%629.17万 | -12.96%330.31万 | -13.70%1,519.21万 | -9.35%1,181.71万 | -5.23%828.48万 | -14.10%379.49万 | 9.11%1,760.48万 | 7.07%1,303.59万 | 0.36%874.18万 |
| 销售费用 | -23.55%3.03亿 | -23.23%2.08亿 | 0.15%1.18亿 | -5.61%4.92亿 | 0.56%3.96亿 | 5.62%2.71亿 | -12.14%1.17亿 | 23.52%5.21亿 | 21.76%3.94亿 | 12.51%2.56亿 |
| 管理费用 | 2.24%5,629.07万 | 11.71%4,133.28万 | 11.46%2,092.31万 | 14.94%7,734.84万 | 16.84%5,505.75万 | 28.55%3,700.17万 | 31.67%1,877.25万 | 31.31%6,729.2万 | 29.64%4,712.1万 | 15.03%2,878.43万 |
| 财务费用 | -3.24%-387.08万 | -18.23%-295.89万 | -32.90%-161.68万 | -12.17%-509.91万 | -11.57%-374.95万 | -8.56%-250.27万 | 9.28%-121.66万 | -449.79%-454.57万 | -1,243.38%-336.07万 | -2,305.19%-230.53万 |
| -利息费用 | -80.30%5,816.5 | -73.74%5,669.51 | -67.35%3,831.38 | 36.29%3.54万 | --2.95万 | --2.16万 | --1.17万 | -99.45%2.6万 | ---- | ---- |
| -利息收入 | -2.23%-391.59万 | -16.55%-298.68万 | -29.93%-163.22万 | -11.83%-522.79万 | -11.79%-383.04万 | -8.97%-256.26万 | 8.41%-125.62万 | 31.19%-467.48万 | 38.11%-342.64万 | 43.04%-235.15万 |
| 研发费用 | -19.55%2,938.34万 | -28.89%2,063.51万 | -45.21%852.06万 | -9.49%4,535.48万 | -4.58%3,652.34万 | 13.13%2,901.92万 | 10.77%1,555.25万 | 5.54%5,010.82万 | -4.48%3,827.49万 | -10.41%2,565.11万 |
| 信用减值损失 | -55.61%67.97万 | -26.60%76.21万 | -39.95%76.04万 | 150.58%123.55万 | 232.19%153.14万 | 208.15%103.82万 | 2,675.82%126.63万 | -339.76%-244.29万 | -238.28%-115.84万 | -64.11%-96万 |
| 资产减值损失 | 59.60%-86.7万 | 42.00%-93.63万 | 40.87%-11.95万 | 47.40%-230.79万 | 33.21%-214.64万 | 27.40%-161.44万 | 83.42%-20.22万 | 72.74%-438.79万 | -199.03%-321.36万 | -731.01%-222.38万 |
| 非经营性净收益 | 69.05%376.12万 | 75.41%254万 | 15.13%242.5万 | 2,861.91%398.86万 | 241.57%222.48万 | 198.46%144.8万 | 785.99%210.63万 | 91.82%-14.44万 | -113.60%-157.16万 | -241.28%-147.07万 |
| 资产处置收益 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --214.73万 | ---- | ---- |
| 其他收益 | 39.04%394.85万 | 34.09%271.42万 | 71.18%178.41万 | 11.50%506.1万 | 1.40%283.98万 | 18.16%202.42万 | 20.27%104.22万 | -65.90%453.91万 | -76.26%280.05万 | -9.53%171.31万 |
| 营业利润 | -44.60%2,643.5万 | -52.72%1,477.31万 | -57.78%1,065.25万 | -49.70%5,648.99万 | -36.16%4,771.4万 | -47.44%3,124.55万 | -10.08%2,522.9万 | -41.71%1.12亿 | -52.60%7,473.6万 | -50.62%5,944.57万 |
| 加:营业外收入 | -70.35%26.22万 | -42.62%29.93万 | 1,055.54%25.23万 | 419.19%104.09万 | 570.16%88.43万 | 846.86%52.16万 | --2.18万 | 103,603.55%20.05万 | 68,157.91%13.2万 | 28,393.69%5.51万 |
| 减:营业外支出 | 294.92%152.61万 | 219.82%112.48万 | 2,260.27%13.17万 | 68.03%289.26万 | -70.82%38.64万 | -70.65%35.17万 | -97.71%5,579.63 | -36.96%172.14万 | -4.72%132.42万 | 95.20%119.84万 |
| 利润总额 | -47.79%2,517.12万 | -55.60%1,394.75万 | -57.33%1,077.3万 | -50.68%5,463.82万 | -34.44%4,821.19万 | -46.12%3,141.54万 | -9.23%2,524.52万 | -41.67%1.11亿 | -52.94%7,354.38万 | -51.32%5,830.24万 |
| 减:所得税费用 | 183.71%503.2万 | 133.88%432.88万 | -33.31%200.96万 | -61.68%801.06万 | -82.47%177.36万 | -83.42%185.09万 | -38.52%301.33万 | -26.98%2,090.72万 | -37.53%1,011.99万 | -39.76%1,116.39万 |
| 净利润 | -56.63%2,013.92万 | -67.47%961.88万 | -60.58%876.34万 | -48.13%4,662.76万 | -26.78%4,643.83万 | -37.28%2,956.45万 | -2.97%2,223.19万 | -44.28%8,988.59万 | -54.72%6,342.38万 | -53.44%4,713.85万 |
| 持续经营净利润 | -56.63%2,013.92万 | -67.47%961.88万 | -60.58%876.34万 | -48.13%4,662.76万 | -26.78%4,643.83万 | -37.28%2,956.45万 | -2.97%2,223.19万 | -44.28%8,988.59万 | -54.72%6,342.38万 | -53.44%4,713.85万 |
| 减：少数股东损益 | 74.73%-277.04万 | 80.85%-146.27万 | 71.91%-90.38万 | 30.63%-1,213.95万 | 30.16%-1,096.3万 | 14.57%-763.95万 | 19.08%-321.74万 | -745.87%-1,750万 | -591.16%-1,569.65万 | -1,463.63%-894.28万 |
| 归属于母公司所有者的净利润 | -60.09%2,290.96万 | -70.21%1,108.15万 | -62.01%966.72万 | -45.27%5,876.71万 | -27.45%5,740.13万 | -33.66%3,720.4万 | -5.35%2,544.93万 | -34.28%1.07亿 | -42.20%7,912.04万 | -44.92%5,608.13万 |
| 每股收益 | ||||||||||
| 基本每股收益 | -60.00%0.04 | -66.67%0.02 | -50.00%0.02 | -47.37%0.1 | -28.57%0.1 | -40.00%0.06 | -20.00%0.04 | -32.14%0.19 | -41.67%0.14 | -44.44%0.1 |
| 稀释每股收益 | -60.00%0.04 | -66.67%0.02 | -50.00%0.02 | -47.37%0.1 | -28.57%0.1 | -40.00%0.06 | -20.00%0.04 | -32.14%0.19 | -41.67%0.14 | -44.44%0.1 |
| 其他综合收益 | ||||||||||
| 综合收益总额 | -56.63%2,013.92万 | -67.47%961.88万 | -60.58%876.34万 | -48.13%4,662.76万 | -26.78%4,643.83万 | -37.28%2,956.45万 | -2.97%2,223.19万 | -44.28%8,988.59万 | -54.72%6,342.38万 | -53.44%4,713.85万 |
| 归属于母公司所有者的综合收益总额 | -60.09%2,290.96万 | -70.21%1,108.15万 | -62.01%966.72万 | -45.27%5,876.71万 | -27.45%5,740.13万 | -33.66%3,720.4万 | -5.35%2,544.93万 | -34.28%1.07亿 | -42.20%7,912.04万 | -44.92%5,608.13万 |
| 归属于少数股东的综合收益总额 | 74.73%-277.04万 | 80.85%-146.27万 | 71.91%-90.38万 | 30.63%-1,213.95万 | 30.16%-1,096.3万 | 14.57%-763.95万 | 19.08%-321.74万 | -745.87%-1,750万 | -591.16%-1,569.65万 | -1,463.63%-894.28万 |
| 货币单位 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 |
| 会计准则 | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) |
| 审计意见 | -- | -- | -- | 无保留意见 | -- | -- | -- | 无保留意见 | -- | -- |
| 会计师事务所 | -- | -- | -- | 永拓会计师事务所(特殊普通合伙) | -- | -- | -- | 永拓会计师事务所(特殊普通合伙) | -- | -- |
FY：Financial Year 年度报告，相当于上市公司向SEC披露的10-K文件。
Q：Quarter 季度报告，相当于上市公司向SEC披露的10-Q文件，其中Q1、Q2、Q3、Q4为单季报，跨度为3个月；Q6、Q9为累计季报，Q6为6个月，Q9为9个月。
热议
沪深
综合热度
股票代码
最新价
涨跌幅
暂无数据
